These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19345476)

  • 1. Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress.
    Cho HY; Thomas S; Golden EB; Gaffney KJ; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
    Cancer Lett; 2009 Sep; 282(1):87-97. PubMed ID: 19345476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
    Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
    Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2.
    Chen ST; Thomas S; Gaffney KJ; Louie SG; Petasis NA; Schönthal AH
    Leuk Res; 2010 Feb; 34(2):250-3. PubMed ID: 19833390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors.
    Thomas S; Sharma N; Golden EB; Cho H; Agarwal P; Gaffney KJ; Petasis NA; Chen TC; Hofman FM; Louie SG; Schönthal AH
    Cancer Lett; 2012 Dec; 325(1):63-71. PubMed ID: 22664238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
    Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
    Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells.
    El-Awady RA; Saleh EM; Ezz M; Elsayed AM
    Toxicol Appl Pharmacol; 2011 Sep; 255(3):271-86. PubMed ID: 21763710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib induces cell apoptosis coupled with up-regulation of the expression of VEGF by a mechanism involving ER stress in human colorectal cancer cells.
    Du H; Li W; Wang Y; Chen S; Zhang Y
    Oncol Rep; 2011 Aug; 26(2):495-502. PubMed ID: 21567098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
    Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC
    Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting apoptosis pathways by Celecoxib in cancer.
    Jendrossek V
    Cancer Lett; 2013 May; 332(2):313-24. PubMed ID: 21345578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
    Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
    Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
    Backhus LM; Petasis NA; Uddin J; Schönthal AH; Bart RD; Lin Y; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1406-12. PubMed ID: 16256796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib transiently inhibits cellular protein synthesis.
    Pyrko P; Kardosh A; Schönthal AH
    Biochem Pharmacol; 2008 Jan; 75(2):395-404. PubMed ID: 17920040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of nelfinavir-induced endoplasmic reticulum stress.
    Brüning A
    Methods Enzymol; 2011; 491():127-42. PubMed ID: 21329798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs.
    Schönthal AH; Chen TC; Hofman FM; Louie SG; Petasis NA
    Expert Opin Investig Drugs; 2008 Feb; 17(2):197-208. PubMed ID: 18230053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.
    Handrick R; Ganswindt U; Faltin H; Goecke B; Daniel PT; Budach W; Belka C; Jendrossek V
    Radiother Oncol; 2009 Mar; 90(3):413-21. PubMed ID: 19038466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
    Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
    J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents.
    Mehar A; Macanas-Pirard P; Mizokami A; Takahashi Y; Kass GE; Coley HM
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1181-7. PubMed ID: 18089846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
    Wang YA; Johnson SK; Brown BL; Dobson PR
    Oncol Rep; 2009 Feb; 21(2):437-42. PubMed ID: 19148520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.